(Q44451378)

English

A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation

scientific article published in June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

liver transplantation

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

María Buti

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Antoni Mas

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Martín Prieto

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Fernando Casafont

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Antonio González

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Manuel Miras

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Jose Ignacio Herrero

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Rossendo Jardí

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Eva Cruz de Castro

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

César García-Rey

10

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

811-817

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

'EUROHEP' consensus report on the management of liver transplantation for hepatitis B virus infection. European Concerted Action on Viral Hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of hepatitis B: 2000--summary of a workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose [...]

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced doses of hepatitis B immunoglobulin protect against hepatitis B virus infection recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation and hepatitis B virus infection: the situation seems to be under control, but the virus is still there

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical utility in quantifying serum HBV DNA levels using PCR assays

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus persistence after recovery from acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900087-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(03)00087-4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44451378&oldid=2105001903"